Cholecystokinin receptors in GtoPdb v.2023.1

  • Margery Beinfeld Tufts University
  • Quan Chen Mayo Clinic
  • Fan Gao Mayo Clinic
  • Roger A. Liddle Duke University
  • Laurence J. Miller Mayo Clinic https://orcid.org/0000-0002-4554-3872
  • Jens Rehfeld University of Copenhagen

Abstract


Cholecystokinin receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on CCK receptors [90]) are activated by the endogenous peptides cholecystokinin-8 (CCK-8), CCK-33, CCK-58 and gastrin (gastrin-17). There are only two distinct subtypes of CCK receptors, CCK1 and CCK2 receptors [64, 124], with some alternatively spliced forms most often identified in neoplastic cells. The CCK receptor subtypes are distinguished by their peptide selectivity, with the CCK1 receptor requiring the carboxyl-terminal heptapeptide-amide that includes a sulfated tyrosine for high affinity and potency, while the CCK2 receptor requires only the carboxyl-terminal tetrapeptide shared by each CCK and gastrin peptides. These receptors have characteristic and distinct distributions, with both present in both the central nervous system and peripheral tissues.

Published
26-Apr-2023
How to Cite
Beinfeld, M., Chen, Q., Gao, F., Liddle, R. A., Miller, L. J. and Rehfeld, J. (2023) “Cholecystokinin receptors in GtoPdb v.2023.1”, IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). doi: 10.2218/gtopdb/F15/2023.1.
Section
Summaries